Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients

Coronavirus disease-2019 (COVID-19) is associated with severe inflammation in mainly the lung, and kidney. Reports suggest a beneficial effect of the use of heparin/low molecular weight heparin (LMWH) on mortality in COVID-19. In part, this beneficial effect could be explained by the anticoagulant p...

Descripción completa

Detalles Bibliográficos
Autores principales: Buijsers, Baranca, Yanginlar, Cansu, Maciej-Hulme, Marissa L., de Mast, Quirijn, van der Vlag, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445140/
https://www.ncbi.nlm.nih.gov/pubmed/32853989
http://dx.doi.org/10.1016/j.ebiom.2020.102969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445140/
https://www.ncbi.nlm.nih.gov/pubmed/32853989
http://dx.doi.org/10.1016/j.ebiom.2020.102969

Ejemplares similares